Literature DB >> 12710960

Cis regulatory requirements for vulval cell-specific expression of the Caenorhabditis elegans fibroblast growth factor gene egl-17.

Mingxue Cui1, Min Han.   

Abstract

The Caenorhabditis elegans EGL-17/FGF protein is involved in the gonadal signaling that guides the migrations of sex myoblasts (SMs). egl-17::GFP reporter constructs are expressed dynamically in vulval cell lineages. Expression in the primary vulval cells is correlated with the precise positioning of SMs. We have investigated the cis-regulatory requirements for cell- and stage-specific expression of egl-17. Three enhancer elements that specify the expression of the egl-17::GFP reporter gene in primary or secondary vulval cells at certain stages were identified. Sequence analysis has suggested a number of potential transcription factor binding sites within the enhancer elements. egl-17 is most likely a direct target of the LIN-39 Hox protein because mutations either in the lin-39/hox gene or at the consensus HOX/PBC binding site within the distal enhancer of the egl-17 gene eliminated distal enhancer-activated egl-17 expression. Since expression of egl-17::GFP driven by the distal enhancer can no longer be turned off at late stages in lin-1 and lin-31 mutants, egl-17 may also be regulated by Ras signaling through repression of LIN-1 and LIN-31 activities. Interspecies transformation experiments showed that egl-17 cis-regulatory elements are structurally and functionally conserved between C. elegans and C. briggsae.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710960     DOI: 10.1016/s0012-1606(03)00033-2

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  21 in total

1.  Transcriptional network underlying Caenorhabditis elegans vulval development.

Authors:  Takao Inoue; Minqin Wang; Ted O Ririe; Jolene S Fernandes; Paul W Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

2.  Cell fate-specific regulation of EGF receptor trafficking during Caenorhabditis elegans vulval development.

Authors:  Attila Stetak; Erika Fröhli Hoier; Assunta Croce; Giuseppe Cassata; Pier Paolo Di Fiore; Alex Hajnal
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

Review 3.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

Review 4.  Transcriptional regulation of gene expression in C. elegans.

Authors:  Valerie Reinke; Michael Krause; Peter Okkema
Journal:  WormBook       Date:  2013-06-04

5.  Allele-specific suppressors of lin-1(R175Opal) identify functions of MOC-3 and DPH-3 in tRNA modification complexes in Caenorhabditis elegans.

Authors:  Sunhong Kim; Wade Johnson; Changchun Chen; Aileen K Sewell; Anders S Byström; Min Han
Journal:  Genetics       Date:  2010-05-17       Impact factor: 4.562

Review 6.  Nucleoside diphosphate kinases (NDPKs) in animal development.

Authors:  Krisztina Takács-Vellai; Tibor Vellai; Zsolt Farkas; Anil Mehta
Journal:  Cell Mol Life Sci       Date:  2014-12-24       Impact factor: 9.261

Review 7.  Invading, Leading and Navigating Cells in Caenorhabditis elegans: Insights into Cell Movement in Vivo.

Authors:  David R Sherwood; Julie Plastino
Journal:  Genetics       Date:  2018-01       Impact factor: 4.562

8.  The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions.

Authors:  Thomas A Berset; Erika Fröhli Hoier; Alex Hajnal
Journal:  Genes Dev       Date:  2005-05-18       Impact factor: 11.361

9.  Characterizing the transcriptional regulation of let-721, a Caenorhabditis elegans homolog of human electron flavoprotein dehydrogenase.

Authors:  Derek S Chew; Allan K Mah; David L Baillie
Journal:  Mol Genet Genomics       Date:  2009-09-23       Impact factor: 3.291

Review 10.  Hox specificity unique roles for cofactors and collaborators.

Authors:  Richard S Mann; Katherine M Lelli; Rohit Joshi
Journal:  Curr Top Dev Biol       Date:  2009       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.